Point Of Care Diagnostics Market By Test (Glucose, Cardiac, HbA1c, HIV, STD, HCV, Pregnancy, Cancer, Hematology), Platform (Immunoassay, Microfluidics, MDx), Mode (Prescription, OTC), End User (Hospital, At Home, OPD) – Global Forecast To 2024

  • Report ID:MRHC - 10499
  • Pages: 293
  • Jan 2019
  • Formats*: PDF
  • Category: Healthcare
1 Introduction

1.1. Currency and Limitations

1.1.1. Currency

1.1.2. Limitations

2 Research Methodology

2.1. Research Process

2.1.1. Secondary Research

2.1.2. Primary Research

2.1.3. Market Size Estimation

3 Executive Summary

4 Market Insights

4.1. Introduction

4.1.1. Drivers

4.1.1.1. Increasing Prevalence of Infectious Diseases

4.1.1.2. Growing Incidence of Target Diseases

4.1.1.3. Technological Advancements and New Products Launches

4.1.1.4. Rising Number of CLIA-Waived PoC Tests

4.1.1.5. Shortage of Skilled Laboratory Technicians

4.1.1.6. Increasing Funding/Investments For the Development of PoC Products

4.1.2. Restraints

4.1.2.1. Presence of Stringent Regulatory Policies

4.1.2.2. Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints

4.1.3. Opportunities

4.1.3.1. Increasing Number of Conferences and Events

4.1.3.2. Growth Opportunities in Emerging Markets

4.1.3.3. PoC Tests with Multiplexing Capabilities

4.1.3.4. Healthcare Transition Converting Lab Tests to PoC Tests

4.1.4. Challenges

4.1.4.1. Lack of Knowledge About the Use of PoC Devices

4.1.4.2. High Cost of PoC Devices

4.2. Regulatory Analysis

4.2.1. North America

4.2.2. Europe

4.2.3. Asia-Pacific

4.2.4. Latin America, Middle East & Africa

4.3. Supply Chain Analysis

4.4. Pricing Analysis

4.5. Market Share Analysis

5 Point of Care Diagnostics Market, by Product

5.1. Introduction

5.2. Blood Glucose Monitoring Testing Products

5.2.1. Strips

5.2.2. Meters

5.2.3. Lancets & Lancing Devices

5.3. Cardiac Metabolism Monitoring Testing Products

5.3.1. Blood Gas/Electrolytes Testing Products

5.3.2. Cardiac Markers

5.3.3. Hba1c Testing Products

5.4. Infectious Disease Testing Products

5.4.1. Influenza Testing Products

5.4.2. HIV Testing Products

5.4.3. Hepatitis C Testing Products

5.4.4. Sexually Transmitted Disease (STD) Testing Products

5.4.5. Healthcare Associated Infection (HAI) Testing Products

5.4.6. Respiratory Infection Testing Products

5.4.7. Tropical Disease Testing Products

5.4.8. Other Infectious Disease Testing Products

5.5. Coagulation Monitoring Products

5.5.1. Prothrombin Time (PT/INR) Testing Products

5.5.2. Activated Clotting Time (ACT/aPTT) Testing Products

5.6. Pregnancy and Fertility Testing Products

5.6.1. Pregnancy Testing Products

5.6.2. Fertility Testing Products

5.7. Fecal Occult Testing Products

5.8. Hematology Testing Products

5.9. Tumor/Cancer Markers Testing Products

5.10. Drugs of Abuse Testing Products

5.11. Urinalysis Testing Products

5.12. Cholesterol Testing Products

5.13. Other PoC Testing Products

6 Point of Care Diagnostics Market, by Platform

6.1. Introduction

6.2. Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)

6.3. Dipsticks

6.4. Microfluidics

6.5. Molecular Diagnostics

7 Point of Care Diagnostics Market, by Mode

7.1. Introduction

7.2. Prescription-Based Testing Products

7.3. Over-the-Counter (OTC) Testing Products

8 Point of Care Diagnostics Market, by End User

8.1. Introduction

8.2. Home Care/Self Testing

8.3. Physician offices & Outpatient/Ambulatory Care Settings

8.4. Hospitals

8.5. Research Laboratories

9 Point of Care Diagnostics Market, by Geography

9.1. Introduction

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. Italy

9.3.3. France

9.3.4. U.K.

9.3.5. Spain

9.3.6. RoE

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. RoAPAC

9.5. RoW

9.5.1. Latin America

9.5.2. Middle East & Africa

10 Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)

10.1. Abbott Laboratories

10.2. AccuBioTech Co., Ltd.

10.3. Becton, Dickinson, and Company (BD)

10.4. Chembio Diagnostic Systems, Inc.

10.5. Danaher Corporation

10.6. EKF Diagnostics Holdings plc

10.7. WerfenLife, S.A.

10.8. Johnson & Johnson Services, Inc.

10.9. Nova Biomedical

10.10. F. Hoffmann-La Roche Ltd.

10.11. Sekisui Chemical Co. Ltd.

10.12. Quidel Corporation

10.13. Siemens AG

10.14. Trinity Biotech

11 Appendix

11.1. Questionnaire

11.2. Available Customization

List of Tables

Table 1 Point of Care Diagnostics Market Drivers: Impact Analysis (2018-2024)
Table 2 Global Point of Care Diagnostics Market Restraints: Impact Analysis (2018-2024)
Table 3 Policy/Guidelines/Standards for PoCT Devices in Europe
Table 4 PoC Regulations in Asia-Pacific
Table 5 PoC Regulations in Rest of the World
Table 6 OEMs for PoC Devices
Table 7 End-Users for PoC Devices
Table 8 Cost Comparison: PoC Test Vs Central Lab Test
Table 9 Price Comparison: Single and Multiple Analyte Tests
Table 10 Point of Care Diagnostics Market Size, by Products, 2016-2024 ($Million)
Table 11 Global Point of Care Diagnostics Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 12 Global Point of Care Diagnostics Market Size for Blood Glucose Monitoring Testing Products, by Country, 2016-2024 ($Million)
Table 13 Global Point of Care Diagnostics Market Size for Strips, by Country, 2016-2024 ($Million)
Table 14 Global Point of Care Diagnostics Market Size for Meters, by Country, 2016-2024 ($Million)
Table 15 Global Point of Care Diagnostics Market Size for Lancets and Lancing Devices, by Country, 2016-2024 ($Million)
Table 16 Global Point of Care Diagnostics Market Size for Cardiac Metabolism Testing Products, by Type, 2016-2024 ($Million)
Table 17 Global POC Diagnostics Market Size for Cardiac Metabolism Testing Products, by Country, 2016-2024 ($Million)
Table 18 Global Point of Care Diagnostics Market Size for Blood Gas/Electrolyte Testing Products, by Country, 2016-2024 ($Million)
Table 19 Commercially Available Tests for Cardiac Biomarker Detection
Table 20 Global Point of Care Diagnostics Market Size for Cardiac Markers, by Country, 2016-2024 ($Million)
Table 21 Global Point of Care Diagnostics Market Size for Hemoglobin A1c Testing Products, by Country, 2016-2024 ($Million)
Table 22 Global Point of Care Diagnostics Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 23 Global POC Diagnostics Market Size for Infectious Disease Testing Products, by Country, 2016-2024 ($Million)
Table 24 Commercially Available CLIA-Waived Tests for Influenza Diagnostics
Table 25 Global Point of Care Diagnostics Market Size for Influenza Testing Products, by Country, 2016-2024 ($Million)
Table 26 Global POC Diagnostics Market Size for HIV Testing Products, by Country, 2016-2024 ($Million)
Table 27 Global POC Diagnostics Market Size for HCV Testing Products, by Country, 2016-2024 ($Million)
Table 28 Global Point of Care Diagnostics Market Size for STD Testing Products, by Country, 2016-2024 ($Million)
Table 29 Global Point of Care Diagnostics Market Size for HAI Testing Products, by Country, 2016-2024 ($Million)
Table 30 Global Point of Care Diagnostics Market Size for Respiratory Infections Testing Products, by Country, 2016-2024 ($Million)
Table 31 Global Point of Care Diagnostics Market Size for Tropical Disease Testing Products, by Country, 2016-2024 ($Million)
Table 32 Global Point of Care Diagnostics Market Size for Other Infectious Disease Testing Products, by Country, 2016-2024 ($Million)
Table 33 Global Point of Care Diagnostics Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 34 Global POC Diagnostics Market Size for Coagulation Monitoring Products, by Country, 2016-2024 ($Million)
Table 35 Global Point of Care Diagnostics Market Size for Prothrombin Time (PT/INR) Testing Products, by Country, 2016-2024 ($Million)
Table 36 Global Point of Care Diagnostics Market Size for Activated Clotting Time (ACT/aPTT) Testing Products, by Country, 2016-2024 ($Million)
Table 37 Global Point of Care Diagnostics Market Size for Pregnancy and Fertility Testing Products, by Types, 2016-2024 ($Million)
Table 38 Global Point of Care Diagnostics Market Size for Pregnancy and Fertility Testing Products, by Country, 2016-2024 ($Million)
Table 39 Global POC Diagnostics Market Size for Pregnancy Testing Products, by Country, 2016-2024 ($Million)
Table 40 Global Point of Care Diagnostics Market Size for Fertility Testing Products, by Country, 2016-2024 ($Million)
Table 41 Global Point of Care Diagnostics Market Size for Fecal Occult Testing Products, by Country, 2016-2024 ($Million)
Table 42 Global Point of Care Diagnostics Market Size for Hematology Testing Products, by Country, 2016-2024 ($Million)
Table 43 Commercially Available PoC Tests for Tumor/ Cancer Markers Testing Products
Table 44 Global Point of Care Diagnostics Market Size for Tumor/Cancer Testing Products, by Country, 2016-2024 ($Million)
Table 45 Global Point-of-Care Diagnostics Market Size for Drugs of Abuse Testing Products, by Country, 2016-2024 ($Million)
Table 46 Global Point of Care Diagnostics Market Size for Urinalysis Testing Products, by Country, 2016-2024 ($Million)
Table 47 Commercially Available Tests for Cardiac Biomarker Detection
Table 48 Global Point of Care Diagnostics Market Size for Cholesterol Testing Products, by Country, 2016-2024 ($Million)
Table 49 Global Point-of-Care Diagnostics Market Size for Other PoC Testing Products, by Country, 2016-2024 ($Million)
Table 50 Point of Care Diagnostics Market Size, by Platform, 2016-2024 ($Million)
Table 51 Commercially Available Tests Based on Lateral Flow Test Strips
Table 52 Global Point of Care Lateral Flow Assay Market Size, by Country, 2016-2024 ($Million)
Table 53 Global Point of Care Dipsticks Market Size, by Country, 2016-2024 ($Million)
Table 54 Global Point-of-Care Microfluidics Market Size, by Country, 2016-2024 ($Million)
Table 55 Global Point-of-Care Molecular Diagnostics Market Size, by Country, 2016-2024 ($Million)
Table 56 Point of Care Diagnostics Market Size, by Mode, 2016-2024 ($Million)
Table 57 Global Point of Care Diagnostics Market Size for Prescription Based Testing Products, by Country 2016-2024 ($Million)
Table 58 Global Point of Care Diagnostics Market Size for Over the Counter Testing Products, by Country 2016-2024 ($Million)
Table 59 Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)
Table 60 Global Point-of-Care Diagnostics Market Size for Home Care, by Country 2016-2024 ($Million)
Table 61 Global Point of Care Diagnostics Market Size for Physician offices & Outpatient/Ambulatory Care Settings, by Country 2016-2024 ($Million)
Table 62 Global Point of Care Diagnostics Market Size for Hospitals, by Country 2016-2024 ($Million)
Table 63 Global Point of Care Diagnostics Market Size for Research Laboratories, by Country 2016-2024 ($Million)
Table 64 Global Point of Care Diagnostics Market Size, by Geography, 2016-2024 ($Million)
Table 65 North America: Point of Care Diagnostics Market Size, by Country, 2016-2024 ($Million)
Table 66 North America: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 67 North America: Point of Care Diagnostics Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 68 North America: Point of Care Diagnostics Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 69 North America: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 70 North America: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 71 North America: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 72 North America: Market Size, by Platform, 2016-2024 ($Million)
Table 73 North America: Market Size, by Mode, 2016-2024 ($Million)
Table 74 North America: Market Size, by End User, 2016-2024 ($Million)
Table 75 U.S.: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 76 U.S.: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 77 U.S.: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 78 U.S.: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 79 U.S.: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 80 U.S.: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 81 U.S.: Market Size, by Platform, 2016-2024 ($Million)
Table 82 U.S.: Market Size, by Mode, 2016-2024 ($Million)
Table 83 U.S.: Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)
Table 84 Canada: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 85 Canada: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 86 Canada: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 87 Canada: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 88 Canada: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 89 Canada: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 90 Canada: Point of Care Diagnostics Market Size, by Platform, 2016-2024 ($Million)
Table 91 Canada: Point of Care Diagnostics Market Size, by Mode, 2016-2024 ($Million)
Table 92 Canada: Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)
Table 93 Europe: Point of Care Diagnostics Market Size, by Country, 2016-2024 ($Million)
Table 94 Europe: Market Size, by Product, 2016-2024 ($Million)
Table 95 Europe: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 96 Europe: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 97 Europe: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 98 Europe: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 99 Europe: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 100 Europe: Market Size, by Platform, 2016-2024 ($Million)
Table 101 Europe: Market Size, by Mode, 2016-2024 ($Million)
Table 102 Europe: Market Size, by End User, 2016-2024 ($Million)
Table 103 Germany: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 104 Germany: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 105 Germany: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 106 Germany: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 107 Germany: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 108 Germany: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 109 Germany: Market Size, by Platform, 2016-2024 ($Million)
Table 110 Germany: Market Size, by Mode, 2016-2024 ($Million)
Table 111 Germany: Market Size, by End User, 2016-2024 ($Million)
Table 112 Italy: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 113 Italy: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 114 Italy: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 115 Italy: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 116 Italy: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 117 Italy: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 118 Italy: Market Size, by Platform, 2016-2024 ($Million)
Table 119 Italy: Market Size, by Mode, 2016-2024 ($Million)
Table 120 Italy: Market Size, by End User, 2016-2024 ($Million)
Table 121 France: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 122 France: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 123 France: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 124 France: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 125 France: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 126 France: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 127 France: Market Size, by Platform, 2016-2024 ($Million)
Table 128 France: Market Size, by Mode, 2016-2024 ($Million)
Table 129 France: Market Size, by End User, 2016-2024 ($Million)
Table 130 U.K.: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 131 U.K.: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 132 U.K.: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 133 U.K.: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 134 U.K.: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 135 U.K.: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 136 U.K.: Point of Care Diagnostics Market Size, by Platform, 2016-2024 ($Million)
Table 137 U.K.: Point of Care Diagnostics Market Size, by Mode, 2016-2024 ($Million)
Table 138 U.K.: Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)
Table 139 Spain: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 140 Spain: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 141 Spain: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 142 Spain: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 143 Spain: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 144 Spain: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 145 Spain: Point of Care Diagnostics Market Size, by Platform, 2016-2024 ($Million)
Table 146 Spain: Point of Care Diagnostics Market Size, by Mode, 2016-2024 ($Million)
Table 147 Spain: Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)
Table 148 RoE: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 149 RoE: Point of Care Diagnostics Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 150 RoE: Point of Care Diagnostics Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 151 RoE: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 152 RoE: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 153 RoE: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 154 RoE: Market Size, by Platform, 2016-2024 ($Million)
Table 155 RoE: Market Size, by Mode, 2016-2024 ($Million)
Table 156 RoE: Market Size, by End User, 2016-2024 ($Million)
Table 157 APAC: Point of Care Diagnostics Market Size, by Country, 2016-2024 ($Million)
Table 158 APAC: Market Size, by Products, 2016-2024 ($Million)
Table 159 APAC: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 160 APAC: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 161 APAC: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 162 APAC: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 163 APAC: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 164 APAC: Market Size, by Platform, 2016-2024 ($Million)
Table 165 APAC: Market Size, by Mode, 2016-2024 ($Million)
Table 166 APAC: Market Size, by End User, 2016-2024 ($Million)
Table 167 Japan: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 168 Japan: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 169 Japan: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 170 Japan: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 171 Japan: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 172 Japan: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 173 Japan: Market Size, by Platform, 2016-2024 ($Million)
Table 174 Japan: Market Size, by Mode, 2016-2024 ($Million)
Table 175 Japan: Market Size, by End User, 2016-2024 ($Million)
Table 176 China: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 177 China: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 178 China: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 179 China: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 180 China: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 181 China: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 182 China: Market Size, by Platform, 2016-2024 ($Million)
Table 183 China: Market Size, by Mode, 2016-2024 ($Million)
Table 184 China: Market Size, by End User, 2016-2024 ($Million)
Table 185 India: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 186 India: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 187 India: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 188 India: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 189 India: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 190 India: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 191 India: Market Size, by Platform, 2016-2024 ($Million)
Table 192 India: Market Size, by Mode, 2016-2024 ($Million)
Table 193 India: Market Size, by End User, 2016-2024 ($Million)
Table 194 RoAPAC: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 195 RoAPAC: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 196 RoAPAC: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 197 RoAPAC: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 198 RoAPAC: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 199 RoAPAC: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 200 RoAPAC: Market Size, by Platform, 2016-2024 ($Million)
Table 201 RoAPAC: Market Size, by Mode, 2016-2024 ($Million)
Table 202 RoAPAC: Market Size, by End User, 2016-2024 ($Million)
Table 203 RoW: Point of Care Diagnostics Market Size, by Country, 2016-2024 ($Million)
Table 204 RoW: Market Size, by Product, 2016-2024 ($Million)
Table 205 RoW: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 206 RoW: Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 207 RoW: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 208 RoW: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 209 RoW: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 210 RoW: Market Size, by Platform, 2016-2024 ($Million)
Table 211 RoW: Market Size, by Mode, 2016-2024 ($Million)
Table 212 RoW: Market Size, by End User, 2016-2024 ($Million)
Table 213 Latin America: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 214 Latin America: Point of Care Diagnostics Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 215 Latin America: Point of Care Diagnostics Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 216 Latin America: Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 217 Latin America: Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 218 Latin America: Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 219 Latin America: Market Size, by Platform, 2016-2024 ($Million)
Table 220 Latin America: Market Size, by Mode, 2016-2024 ($Million)
Table 221 Latin America: Market Size, by End User, 2016-2024 ($Million)
Table 222 Middle East & Africa: Point of Care Diagnostics Market Size, by Product, 2016-2024 ($Million)
Table 223 Middle East & Africa: Market Size for Blood Glucose Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 224 Middle East & Africa: Point of Care Diagnostics Market Size for Cardiac-Metabolism Monitoring Testing Products, by Type, 2016-2024 ($Million)
Table 225 Middle East & Africa: Point of Care Diagnostics Market Size for Infectious Disease Testing Products, by Type, 2016-2024 ($Million)
Table 226 Middle East & Africa: Point of Care Diagnostics Market Size for Coagulation Monitoring Products, by Type, 2016-2024 ($Million)
Table 227 Middle East & Africa: Point of Care Diagnostics Market Size Pregnancy and Fertility Testing Products, by Type, 2016-2024 ($Million)
Table 228 Middle East & Africa: Point of Care Diagnostics Market Size, by Platform, 2016-2024 ($Million)
Table 229 Middle East & Africa: Point of Care Diagnostics Market Size, by Mode, 2016-2024 ($Million)
Table 230 Middle East & Africa: Point of Care Diagnostics Market Size, by End User, 2016-2024 ($Million)

List of Figures

Figure 1 Market Ecosystem
Figure 2 Key Stakeholders
Figure 3 Research Process
Figure 4 Key Executives Interviewed
Figure 5 Primary Research Techniques
Figure 6 Market Size Estimation
Figure 7 Meticulous Research Estimates: Blood Glucose Monitoring Testing Products Vs Infectious Disease Testing Products
Figure 8 Meticulous Research Estimates: Prescription-Based Testing Products Vs Over the Counter (OTC) Testing Products
Figure 9 Key Adopters of Point of Care Diagnostics Market
Figure 10 Point of Care Diagnostics Market Overview:2018-2024
Figure 11 Market Dynamics
Figure 12 Leading Causes of Communicable Deaths in Low Income Countries, 2016, (Per 100,000 Population)
Figure 13 Global Number of Reported Cases for Target Disease, (In Thousands), 2013-2017
Figure 14 Global Number of New HIV Infections in Children Aged 0-14 Years Old, 2000-2016 (In Thousands)
Figure 15 Growth of CLIA Waived PoCT Testing, 2000-2017 (Units)
Figure 16 Total Healthcare Spending in Developing Countries, 2015-2030, (In USD)
Figure 17 Disposable Personal Income in China (In USD)
Figure 18 Supply Chain Analysis for Point of Care Diagnostics Market
Figure 19 Global Point of Care Diagnostics Market Share, by Key Players
Figure 20 Point of Care Diagnostics Market Size, by Product, 2018-2024 ($Million)
Figure 21 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
Figure 22 Global Number of People Living with HIV in 2016, (In Millions)
Figure 23 Number of People (All Ages) Living with HIV, 2017 (In Millions)
Figure 24 Number of New Cases of Hepatitis C Virus (HCV), U.S., 2010-2016
Figure 25 Number of Women Aged 10-17 Years, by Region, 2010-2030
Figure 26 Most Common Cancers Death Globally, 2018 (In Million)
Figure 27 Global Trends in Number of Drug Users and People with Drug User Disorders, 2006-2015
Figure 28 Point-of-Care Diagnostics Market Size, by Platform, 2018-2024 ($Million)
Figure 29 Point-of-Care Diagnostics Market Size, by Mode, 2018-2024 ($Million)
Figure 30 Point-of-Care Diagnostics Market Size, by End User, 2018-2024 ($Million)
Figure 31 U.S.: Home Healthcare Spending, 2015-2026
Figure 32 Total Number of Registered Hospitals in Top Ten Countries, 2017
Figure 33 Global Point of Care Diagnostics Market Size, by Geography, by Region, 2018-2024 ($Million)
Figure 34 Life Expectancy at Birth by Region: 2015-2050 (In Years)
Figure 35 North America: Point of Care Diagnostics Market Size, by Country, 2018-2024 ($Million)
Figure 36 Number of People with Chronic Diseases in America: 2005-2030 (Million)
Figure 37 Aging Population in Canada
Figure 38 Facts of Cancer in Canada, 2017
Figure 39 Population Aged 65 and Over by Region, 2015 and 2050
Figure 40 Total Number of Deaths From CVD, by Country, 2014-2020
Figure 41 Europe: Point of Care Diagnostics Market Size, by Country, 2018-2024 ($Million)
Figure 42 Percentage of Older People (65 Years and Above) in France, 2000-2050
Figure 43 Share of Aged Population in the Total Population of the U.K., 2005-2045
Figure 44 Incidence of CVD, IHD and Stroke in Spain, by Sex, 2015
Figure 45 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 46 APAC: Point-of-Care Diagnostics Market Size, by Country, 2018-2024 ($Million)
Figure 47 China Population Growth Chart, 2010-2040
Figure 48 RoW: Point-of-Care Diagnostics Market Size, by Country, 2018-2024 ($Million)
Figure 49 Abbott Laboratories: Financial Overview-2015-2017
Figure 50 Becton Dickinson and Company: Financial Overview-2016-2018
Figure 51 Chembio Diagnostic Systems, Inc.: Financial Overview-2015-2017
Figure 52 Danaher Corporation: Financial Overview-2015-2017
Figure 53 EKF Diagnostics Holdings plc: Financial Overview-2015-2017
Figure 54 WerfenLife, S.A.: Financial Overview-2015-2017
Figure 55 Johnson and Johnson Service, Inc.: Financial Overview-2015-2017
Figure 56 F. Hoffmann-La Roche Ltd.: Financial Overview-2015-2017
Figure 57 Sekisui Chemical Co. Ltd.: Financial Overview-2015-2017
Figure 58 Quidel Corporation: Financial Overview-2015-2017
Figure 59 Siemens AG: Financial Overview-2015-2017
Figure 60 Trinity Biotech: Financial Overview-2015-2017

The global point of care diagnostics market is expected to grow at a CAGR of 8% from 2018 to reach $30.9 billion by 2024. Point of Care (POC) testing is medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. It is typically performed by non-laboratory personnel and the results are used for clinical decision making. The factors such as rising prevalence of diseases resulting in subsequent increase in demand for better treatment and rapid diagnostic services, and staff shortages in clinical laboratories are primarily driving the demand for POC diagnostics.

Growing Focus on Microfluidics Platform to Fuel the Growth of Point of Care Diagnostics Market 

The simplicity and efficiency of point of care diagnostics have revolutionized patient care. With the advancing field of microfluidics, POC technologies have also developed and improved. Methods in microfabrication and microfluidics have progressed so much in the last few years that POC devices can be fabricated at low cost, are easy to use, portable, and can generate rapid results. There are many research activities on-going in the field of microfluidics technology. For instance, according to a publication from Asian Scientist Magazine in January 2018, a team of scientists led by Professor Masayoshi Tonouchi at Osaka University, Japan – have developed a diagnostic lab-on-a-chip which combines terahertz (THz) waves with a microfluidic device. Further, according to a press release from Japan Science and Technology (JST) Agency in May 2016 – a research team at RIKEN (research institute in Japan) developed world’s thinnest glass-based flexible microfluidic chip. 

                                            Click here to: Get Free Request Sample Copy of this report

Key Findings in the Global Point of Care Diagnostics Market Study: 

Blood glucose monitoring testing kits generated large proportion of revenue

Factors such as high prevalence of diabetic population, need for early detection of hypo and hyperglycemic diabetes, convenience of continuous glucose monitoring over conventional monitoring, greater awareness and availability of glucose monitors across the globe, and growing technological innovations drives the adoption of glucose monitoring testing kits. 

Lateral flow assay (immunochromatography tests/lateral flow immunoassays) technology, to continue dominate the POC diagnostics market through 2024 

Affordability and clinical utility of lateral flow assays in POC applications, makes it the most widely used platform. Moreover, this technology continues to evolve as POC testing demands higher performance. Lateral flow assays are expected to continue dominate the POC testing market; however, POC molecuar diagnostics is rapidly gaining traction.

Over-the-counter (OTC) testing kits to witness the fastest growth during the projected period 

The trend towards the adoption of OTC over prescription kits is mainly due to the cost reduction; convenience to patients and clinicians; quality improvement (when the frequency of performing a particular test in the hospital laboratory is low); and growing use of novel technologies such as nanotechnology, microfluidics, electrical impedance, reflectance, and time-resolved fluorescence, which enables the miniaturization of devices and the proliferation of point-of-care (POC) testing.

Home care/self-testing to dominate the global POC diagnostics market

Home care/self-testing commanded the largest share of the global point of care diagnostics market, owing to the mounting inclination for at home healthcare, growing focus on continuous and remote monitoring, and expanding need for rapid tests among home care users.

Asia-Pacific: Fastest growing regional market

North America commanded the largest share of the global point of care diagnostics market; however, Asia-Pacific is poised to be the fastest growing regional market due to the accelerated growth of economies, increasing population living with various infectious diseases; lower regulatory hurdles, and rising accessibility to healthcare services and POC products.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading companies in the industry over the past 4 years (2015-2018). The key players profiled in the global point of care diagnostics market research report are Abbott Laboratories, AccuBioTech Co., Ltd., Becton Dickinson and Company, Chembio Diagnostic Systems, Inc., Danaher Corporation, EKF Diagnostics Holdings plc, WerfenLife, S.A., Johnson and Johnson Service, Inc., Nova Biomedical, F. Hoffmann-La Roche Ltd, Sekisui Diagnostics LLC, Quidel Corporation, Siemens AG, and Trinity Biotech.

Scope of the Report: 

Point Of Care Diagnostics Market by Product:

  • Blood Glucose Monitoring Testing Products
    • Strips
    • Meters
    • Lancets & Lancing Devices
  • Cardiac-Metabolism Monitoring Testing Products
    • Cardiac Marker
    • Blood Gas/Electrolytes Testing
    • HbA1c Testing
  • Infectious Disease Testing Products
    • Influenza Testing
    • HIV Testing
    • Hepatitis C Testing
    • Sexually Transmitted Disease (STD) Testing
    • Healthcare-Associated Infection (HAI) Testing
    • Respiratory Infection Testing
    • Tropical Disease Testing
    • Other Infectious Disease Testing
  • Coagulation Monitoring Products
    • Prothrombin Time (PT/INR) Testing
    • Activated Clotting Time (ACT/aPTT) Testing
  • Pregnancy and Fertility Testing Products
    • Pregnancy Testing
    • Fertility Testing
  • Tumor/Cancer Markers Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs of Abuse Testing Products
  • Fecal Occult Testing Products
  • Other POC Testing Products

Point Of Care Diagnostics Market by Platform:

  • Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics

Point Of Care Diagnostics Market by Mode:

  • Prescription-based Testing
  • Over-the-counter (OTC) Testing

Point Of Care Diagnostics Market by End User:

  • Home Care/Self-testing
  • Physician Offices & Outpatient/Ambulatory Care Settings
  • Hospitals
  • Research Laboratories

Point Of Care Diagnostics Market by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

Growing penetration of PoC tests in developing countries will propel the overall point of care diagnostics market

  • How does the penetration of PoC tests in developed regions differ from developing countries like China, India, and Japan?
  • How is the competition between the major global and prominent local players in this market?
  • Which are the high growth market segments in terms of product, platform, prescription mode, end users, and geography?

Home Care/Self Testing accounted for the largest share of the point of care diagnostics market

  • What factors are contributing to the frequent usage of PoC tests in home care/self-testing?
  • How does the penetration of PoC tests in home care/self-testing differ from other end users?

Point of care diagnostics market favors both global and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • Which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter in this market?
  • What are the major drivers, restraints, opportunities, and challenges in the point of care diagnostics market?
  • How is the regulatory scenario for PoC across the globe?
  • What are the geographical trends and high growth regions/countries?

Recent partnerships, acquisitions, and expansions have taken place in the global point of care diagnostics market

  • Which companies have recently merged/acquired and how will these unions affect the competitive landscape of the point of care diagnostics market?
  • Which companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global point of care diagnostics market and what share of the market do they hold?
  • What are the local emerging players in the global point of care diagnostics market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare In Vitro Diagnostics
Download Free Sample
to